Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

JOHNSON & JOHNSON (JNJ) Stock Price Prediction and News Highlight
Sun. Oct 12, 2025

Recent advancements in ulcerative colitis treatments highlight the strong focus on product development, with positive Phase 3 trial results contributing to clinical efficacy. Additionally, innovations in contact lens technology and healthcare products underscore Johnson & Johnson's commitment to enhancing patient experience and maintaining competitive advantages in the market. The ongoing potential for new products further suggests a robust pipeline for future successes.

The price action of JOHNSON & JOHNSON (JNJ) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at -0.1 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for JNJ since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.1, and the negative at -0.2 on 2025-10-12. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (0.7) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2025-10-14 06:30, EPS: $9.34, P/E: 20.42

JNJ
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2025-10-120%(0%)    0    0%    -0.1          0.7    -1   
2025-10-110%(0%)    0    0%    -0.1          0.2    -1   
2025-10-100%(0%)    0    0%    -0          0.9    5   
2025-10-090%(0%)    0    0%    0.1          1.3    -1   
2025-10-080%(0%)    0    0%    0          1.2    7   
2025-10-070%(0%)    0    0%    0          1.2    -9   
2025-10-060%(0%)    0    0%    0.4          3.5    -1   
2025-10-050%(0%)    0    0%    0.5          4.2    -1   
2025-10-040%(0%)    0    0%    0.5          4.2    -1   
2025-10-030%(0%)    0    0%    0.5          4.2    6   
 
Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.
Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2025-10-12 17:01:45 The articles hint at J&J's strategic decisions for growth through partnerships and acquisitions, indicating a focus on maintaining a competitive advantage.
2025-10-12 17:01:45 The focus on Protagonist Therapeutics' products and their potential for success under J&J highlights ongoing product development opportunities.
2025-10-12 17:01:45 The discussion of stock purchases and the associated value reflects insights into how investors perceive Johnson & Johnson's stock performance.
2025-10-12 17:01:45 The articles cover speculation about Johnson & Johnson's potential acquisition of Protagonist Therapeutics, suggesting positive implications for the company's future.
2025-10-12 17:01:45 Both articles discuss recent investments and acquisitions related to Johnson & Johnson, highlighting the company's active role in the market and potential growth through acquisitions.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA